Delivery of retained placenta .

Phase 2

• Conditions: Condition 1: Retained placenta. Condition 2: Retained placenta. Condition 3: Retained placenta.; Retained placenta without haemorrhage; Morbidly adherent placenta; Sequelae of complication of pregnancy, childbirth and the puerperium

• Registration Number: IRCT201405222624N16
• Lead Sponsor: Vice chancellor for research ,Iran University of Medical Sciences.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 80

Inclusion Criteria

Inclusion criteria : maternal age between 18- 40; gestational age of 26 completed weeks and more; singleton; vaginal delivery and no placental delivery up to 30 minutes after neonatal birth despite of intramuscular oxitocine prescription and controlled cord traction .
Exclusion criteria: any known systemic disorders; severe bleeding; known uterine malformations and suspicion for placenta accreta.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Delivery of retained placenta. Timepoint: 5 minutes after prescription. Method of measurement: Data sheets.

Secondary Outcome Measures

Name	Time	Method
Amount of bleeding. Timepoint: the day after delivery. Method of measurement: hemoglobin concentration.